BREAST CARCINOMA-ASSOCIATED ANTIGEN (CA 27.29) | LABCORP OKLAHOMA, INC. | Test Directory

Labcorp Oklahoma, Inc.
Test Directory

Index:

Print Test Information

Breast Carcinoma-Associated Antigen (CA 27.29)

Order Name CA2729
Revision Date 10/16/2019

Test Name	Methodology	LOINC Code
Breast Carcinoma-Associated Antigen (CA 27.29)

SPECIMEN REQUIREMENTS
Specimen	Specimen Volume (min)	Specimen Type	Specimen Container	Transport Environment
Preferred	0.5 mL (0.25 mL)	Serum	Serum Gel Tube	Refrigerated
Alternate 1	0.5 mL (0.25 mL)	Serum	Red Top	Refrigerated
Instructions	Label specimen with Mobilab label or with patient name (first and last), date of birth, date and time of collection, collector initials, and test(s) being ordered.
Reference Range	Males > or =18 years: < or =38.0 U/mL (use not defined) Females > or =18 years: < or =38.0 U/mL Reference values have not been established for patients who are <18 years of age. Serum markers are not specific for malignancy, and values may vary by method. Interpretation Increased levels of cancer-associated antigen (CA 27.29) (>38 U/mL) may indicate recurrent disease in a woman with treated breast carcinoma.
Methodology	Breast Carcinoma-Associated Antigen (CA 27.29),

GENERAL INFORMATION
Testing Schedule	Monday-Friday; 6 a.m.-3 p.m.
Expected TAT	2-4 Days
Notes	Specimen Stability: Frozen (preferred) - 90 Days Refrigerated - 7 Days Ambient - 4 Days
CPT Code(s)	86300
Lab Section	NRLS-Mayo Medical Laboratories